Omega Healthcare Investors (OHI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Omega Healthcare Investors is downgraded from bullish to neutral as valuation now reflects its recovery and growth prospects. OHI's dividend is well covered, with payout ratios at 82% of AFFO and 86% of FAD, and management hints at a possible raise in 2027. Active portfolio management, capital recycling, and a strategic pivot toward RIDEA and senior housing are driving operational improvements and future growth potential.
Omega Healthcare Investors offers a compelling high-yield opportunity after a recent price pullback, now yielding over 6%. OHI's fundamentals are robust, with FAD per share up 9.5% YoY, improved dividend coverage at 86%, and tenant rent coverage at a decade high. Strategic expansion into RIDEA structures and value-added acquisitions positions OHI for potentially strong total returns.
Omega Healthcare Investors, Inc. (OHI) Q1 2026 Earnings Call Transcript
Omega Healthcare Investors is rated Buy, with strong long-term potential and a valuation reflecting elevated risk. OHI delivered a solid Q1, raised 2026 AFFO guidance to $3.19–$3.25 per share, and advanced its SHOP/RIDEA operational pivot. Risks include macro headwinds from the Iran conflict, higher rates, tenant pressures, and increased operational exposure from the SHOP model.
Omega Healthcare Investors (OHI) came out with quarterly funds from operations (FFO) of $0.82 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to FFO of $0.75 per share a year ago.
Advisors Capital Management LLC boosted its holdings in Omega Healthcare Investors, Inc. (NYSE: OHI) by 2.0% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 936,433 shares of the real estate investment trust's stock after purchasing an additional 18,342 shares
CPC Advisors LLC acquired a new stake in shares of Omega Healthcare Investors, Inc. (NYSE: OHI) in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 68,790 shares of the real estate investment trust's stock, valued at approximately $3,050,000.
Earned income has a ceiling. But passive income from dividends operates differently: Once established, cash flows in regardless of effort, and the only limit on it is how much you invest in the stocks of companies providing that yield.
Investors aren't putting cash under their mattresses, but they're certainly looking to take some risk off the table. This means rotation out of high-growth technology stocks and looking for value.
Omega Healthcare Investors (OHI) is reiterated as a Buy, supported by strong Q4 results, robust guidance, and potential for dividend increases. OHI's AFFO growth continued, with 2026 guidance implying continued expansion and a solid 5.92% dividend yield at an ~87% payout ratio. Balance sheet strength is underpinned by well-laddered, mostly fixed-rate debt, a new $2.3B credit facility, and recent $600M notes at 5.2%.
Omega Healthcare Investors, Inc. (OHI) Q4 2025 Earnings Call Transcript